FDA Investigator

Shafiq Ahadi

Latest inspection on record: Ridgefield, United States, May 2026 · records back to 2010

Medical Devices & Rad HealthBiologicsHuman DrugsAnimal Drugs & FeedsFoods & Cosmetics

FDA inspection record · Last updated August 15, 2026

Overview

  • 199 inspections across 188 sites are on record.
  • 516 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2026-05-19.

At a glance

Inspections

199

Sites

188

Observations

516

Career since

Nov 2010

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Patheon Manufacturing Services LLC19 May 2026BiologicsView 483 →
GlaxoSmithKline Biologicals SA27 Feb 2026BiologicsView 483 →
GlaxoSmithKline Biologicals SA27 Feb 2026BiologicsOn file
BAXALTA US INC.26 Nov 2025BiologicsView 483 →
Baxter Healthcare Corporation25 Nov 2025BiologicsView 483 →

Sites inspected

Patheon Manufacturing Services LLCRidgefield, United States1 insp.
GlaxoSmithKline Biologicals SAWavre, Belgium1 insp.
GlaxoSmithKline Biologicals SARixensart, Belgium1 insp.
BAXALTA US INC.Round Lake, United States1 insp.
Baxter Healthcare CorporationRound Lake, United States1 insp.

Co-investigators

Investigators who share inspections with this person.

Full investigator report

Get the verbatim findings behind Shafiq Ahadi's 516 observations

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site